BrainStorm Cell Therapeutics Inc. Hosting A Conference Call With Clinical Trial Advisors In Israel, US And Brazil To Update Shareholders On Current Developments
1/15/2014 8:57:15 AM
NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it will hold a conference call on Thursday, January 30, 2014 at 8:45 a.m. Eastern Standard Time (EST), 15:45 Israel Standard Time (IST).
Help employers find you! Check out all the jobs and post your resume.
comments powered by